RxDoctor Payments Data

Kristen Pollich, MD

Family Medicine · Benton, ARNPI 1053449694

Payments from drug & device makers

$1,688in general payments, 2019–2025

Across 114 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$763
  • GSK$185
  • Amgen$178
  • Pfizer$120
  • Astellas Pharma US Inc$81
  • Novartis$54
  • plus $306 from 16 others

What the payments were for

  • Food & beverage$1,688100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,688 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$72,470
Medicare patients
219
Services billed
1,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$88,648
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$35,746
MounjaroTirzepatide28$29,404
JardianceEmpagliflozin27$20,434
EliquisApixaban24$18,564
FarxigaDapagliflozin Propanediol24$14,286
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$12,550
XareltoRivaroxaban13$11,885
MyrbetriqMirabegron16$7,298
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$6,386
Levothyroxine Sodium356$3,293
Bupropion XlBupropion Hcl134$3,225
Semglee (Yfgn)Insulin Glargine-Yfgn11$2,887
Omeprazole211$2,796
Pantoprazole Sodium195$2,460

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$88,64868 claims
GSKTrelegy Ellipta$185$35,74648 claims
Lilly USA, LLCMounjaro$13$29,40428 claims
PfizerEliquis$120$18,56424 claims
AstraZenecaFarxiga$18$14,28624 claims
Johnson & JohnsonXarelto$13$11,88513 claims
Astellas Pharma US IncMyrbetriq$81$7,29816 claims
AbbVieSynthroid$763$1,38615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Benton

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →